Abbott just received FDA approval for the Absorb coronary heart stent, the first and only fully resorbable stent available in the U.S. We’re kind of surprised the company is calling it what it is and isn’t pushing the new term “scaffold” on us. Nevertheless, while it is novel, the device isn’t exactly a new product, having been approved in the EU already six years ago, available in over 100 countries, and having gone through years of study.
A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the medical device industry. As a District Sales Manager for Stryker Orthopaedics, Peter was responsible for managing and directing a regional sales force to achieve sales and profit goals within the Rocky Mountain region. Previously, he was the Director of Sales & Marketing for Amp Orthopedics. In this role, Peter was responsible for planning, developing, and leading all sales and marketing initiatives. Peter is a former orthopedic distributor in the Pacific Northwest. He has also worked with DePuy Orthopaedics as well as Zimmer, and held positions in sales, sales training, and sales management. Peter has an extensive background in organizational development, business development, sales management, negotiating and P&L management. Peter holds a B.S. degree in Biology from Northern Illinois University.
The federal Medicare agency has endorsed the use of unique identification numbers in billing records for medical devices, a move safety advocates say is crucial in helping detect malfunctions in devices such as heart defibrillators, […]
Orthopedics This Week – K2M Group Holdings, Inc. stakes claim to be the first leading spine company to market a 3D-printed titanium interbody device. Now the company is adding to its portfolio after receiving 510(k) clearance for its MOJAVE PL 3D Expandable Interbody System. […]
CB Insights – As medical device companies gain traction, large corporates such as Medtronic, Boston Scientific, and Teleflex are competing in the race to acquire private medical device startups targeting neurosurgery, orthopedics, and cardiology, among other areas. […]